Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 1294 entries
View as:

Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

Phase: N/A Priority: Normal
NCT ID: NCT02617693 Org: User:
Start: 11/23/15 End: 12/09/17 Due: 12/09/18

A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01006057 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02151409 Org: User:
Start: 06/30/08 End: 10/31/09 Due: 10/31/10

Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)

Phase: N/A Priority: Normal
NCT ID: NCT06351748 Org: User:
Start: 01/02/24 End: 03/29/24 Due: 03/29/25

A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02146079 Org: User:
Start: 05/21/14 End: 10/20/14 Due: 10/20/15

A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06336005 Org: User:
Start: 03/28/24 End: 02/17/25 Due: 02/17/26

Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Phase: N/A Priority: Normal
NCT ID: NCT00722540 Org: User:
Start: 07/31/08 End: 04/30/09 Due: 04/30/10

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

Phase: N/A Priority: Normal
NCT ID: NCT05262595 Org: User:
Start: 03/03/22 End: 09/05/22 Due: 09/05/23

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

Phase: N/A Priority: Normal
NCT ID: NCT00696657 Org: User:
Start: 06/03/08 End: 02/05/09 Due: 02/05/10

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)

Phase: N/A Priority: Normal
NCT ID: NCT03648281 Org: User:
Start: 08/24/18 End: 01/10/20 Due: 01/10/21

A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04857398 Org: User:
Start: 04/28/21 End: 04/06/22 Due: 04/06/23

Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01076634 Org: User:
Start: 02/28/10 End: 07/31/10 Due: 07/31/11

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06326060 Org: User:
Start: 03/18/24 End: 05/01/25 Due: 05/01/26

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06409130 Org: User:
Start: 05/20/24 End: 01/01/26 Due: 01/01/27

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

Phase: N/A Priority: Normal
NCT ID: NCT03611582 Org: User:
Start: 08/01/18 End: 04/28/20 Due: 04/28/21

A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06291285 Org: User:
Start: 02/27/24 End: 06/10/24 Due: 06/10/25

Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06069895 Org: User:
Start: 10/04/23 End: 04/23/25 Due: 04/23/26

A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT05870670 Org: User:
Start: 05/15/23 End: 10/16/23 Due: 10/16/24

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

Phase: N/A Priority: Normal
NCT ID: NCT05035082 Org: User:
Start: 09/01/21 End: 06/09/25 Due: 06/09/26

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT05636176 Org: User:
Start: 05/08/23 End: 07/02/27 Due: 07/02/28

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04596631 Org: User:
Start: 11/02/20 End: 02/04/26 Due: 02/04/27

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04865770 Org: User:
Start: 04/28/21 End: 11/21/24 Due: 11/21/25

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT02607306 Org: User:
Start: 11/18/15 End: 12/22/17 Due: 12/22/18

A Research Study Looking at New Protein-based Tablets in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05129891 Org: User:
Start: 11/03/21 End: 05/04/23 Due: 05/04/24

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT04059367 Org: User:
Start: 08/15/19 End: 01/02/20 Due: 01/02/21